{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Vehicle+%28non-treatment%29&page=2", "query": { "intervention": "Placebo Vehicle (non-treatment)", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 71, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Vehicle+%28non-treatment%29&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Vehicle+%28non-treatment%29&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-08T19:09:30.670Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02654769", "title": "A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Actinic Keratosis" ], "interventions": [ { "name": "Ingenol Mebutate (Picato®)", "type": "DRUG" }, { "name": "Generic Ingenol Mebutate", "type": "DRUG" }, { "name": "Vehicle Foam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "18 Years to 95 Years" }, "enrollment_count": 441, "start_date": "2015-02", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2020-05-12", "last_synced_at": "2026-10-08T19:09:30.670Z", "location_count": 22, "location_summary": "Fremont, California • San Diego, California • Aventura, Florida + 19 more", "locations": [ { "city": "Fremont", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Aventura", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "North Miami Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02654769" }, { "nct_id": "NCT04113109", "title": "Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "LCZ 696", "type": "DRUG" }, { "name": "Icatibant", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "Para-aminohippurate", "type": "DRUG" }, { "name": "Iohexol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2019-11-01", "completion_date": "2025-07-30", "has_results": true, "last_update_posted_date": "2026-08-11", "last_synced_at": "2026-10-08T19:09:30.670Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04113109" }, { "nct_id": "NCT03200912", "title": "An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "ACTINIC KERATOSIS" ], "interventions": [ { "name": "Ingenol Mebutate (Picato®)", "type": "DRUG" }, { "name": "Generic Ingenol Mebutate", "type": "DRUG" }, { "name": "Vehicle Foam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "18 Years to 95 Years" }, "enrollment_count": 507, "start_date": "2016-08-19", "completion_date": "2017-03-22", "has_results": true, "last_update_posted_date": "2020-01-14", "last_synced_at": "2026-10-08T19:09:30.670Z", "location_count": 23, "location_summary": "Oceanside, California • Denver, Colorado • Aventura, Florida + 20 more", "locations": [ { "city": "Oceanside", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Aventura", "state": "Florida" }, { "city": "Brandon", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03200912" }, { "nct_id": "NCT05332366", "title": "A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Frontal Fibrosing Alopecia" ], "interventions": [ { "name": "Delgocitinib cream", "type": "DRUG" }, { "name": "Delgocitinib cream vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2022-04-19", "completion_date": "2023-05-22", "has_results": true, "last_update_posted_date": "2025-03-06", "last_synced_at": "2026-10-08T19:09:30.670Z", "location_count": 1, "location_summary": "Burlington, Massachusetts", "locations": [ { "city": "Burlington", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05332366" }, { "nct_id": "NCT02014376", "title": "Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Epidermolysis Bullosa" ], "interventions": [ { "name": "SD-101 dermal cream (3%)", "type": "DRUG" }, { "name": "SD-101 Dermal Cream (6%)", "type": "DRUG" }, { "name": "Vehicle (SD-101 0%)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Scioderm, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": null, "sex": "ALL", "summary": "6 Months and older" }, "enrollment_count": 48, "start_date": "2014-01-06", "completion_date": "2014-06-24", "has_results": true, "last_update_posted_date": "2020-01-13", "last_synced_at": "2026-10-08T19:09:30.670Z", "location_count": 7, "location_summary": "Palo Alto, California • Chicago, Illinois • St Louis, Missouri + 4 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Hackensack", "state": "New Jersey" }, { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02014376" }, { "nct_id": "NCT03287791", "title": "A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rosacea" ], "interventions": [ { "name": "Generic Azelaic Acid Foam", "type": "DRUG" }, { "name": "Finacea® (Azelaic Acid) Foam", "type": "DRUG" }, { "name": "Vehicle Foam", "type": "DRUG" }, { "name": "Cleanser", "type": "OTHER" }, { "name": "Sunscreen", "type": "OTHER" }, { "name": "Towel", "type": "OTHER" }, { "name": "Moisturizing Lotion", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 924, "start_date": "2016-07-19", "completion_date": "2017-06-22", "has_results": true, "last_update_posted_date": "2019-07-31", "last_synced_at": "2026-10-08T19:09:30.670Z", "location_count": 26, "location_summary": "Encino, California • La Mesa, California • Brandon, Florida + 20 more", "locations": [ { "city": "Encino", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Brandon", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03287791" }, { "nct_id": "NCT04649229", "title": "Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "LCZ 696", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Para-aminohippurate", "type": "DRUG" }, { "name": "Iohexol", "type": "DRUG" }, { "name": "Aprepitant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2021-05-27", "completion_date": "2025-05-22", "has_results": false, "last_update_posted_date": "2026-03-17", "last_synced_at": "2026-10-08T19:09:30.670Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT04649229" }, { "nct_id": "NCT00093249", "title": "Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "clevidipine", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Medicines Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 105, "start_date": "2004-01", "completion_date": "2004-11", "has_results": false, "last_update_posted_date": "2014-08-22", "last_synced_at": "2026-10-08T19:09:30.670Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Los Angeles, California • Hudson, Florida + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Hudson", "state": "Florida" }, { "city": "Pensacola", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00093249" }, { "nct_id": "NCT00847912", "title": "CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Carcinoma, Basal Cell", "Carcinoma, Squamous Cell", "Skin Neoplasms", "Skin Diseases", "Neoplasms, Basal Cell", "Neoplasms, Squamous Cell", "Carcinoma" ], "interventions": [ { "name": "5-fluorouracil", "type": "DRUG" }, { "name": "Placebo, vehicle control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 954, "start_date": "2009-06-26", "completion_date": "2016-07-30", "has_results": true, "last_update_posted_date": "2021-06-11", "last_synced_at": "2026-10-08T19:09:30.670Z", "location_count": 13, "location_summary": "Palo Alto, California • San Diego, California • Denver, Colorado + 10 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Bay Pines", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00847912" }, { "nct_id": "NCT01145807", "title": "TDT 067 Onychomycosis Study", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Onychomycosis" ], "interventions": [ { "name": "TDT067", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Transfersome", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celtic Pharma Development Services", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 738, "start_date": "2010-04", "completion_date": "2012-08", "has_results": false, "last_update_posted_date": "2012-08-01", "last_synced_at": "2026-10-08T19:09:30.670Z", "location_count": 1, "location_summary": "Albequerque, New Mexico", "locations": [ { "city": "Albequerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT01145807" } ] }